Stakes Rise for Blown Batches

Published on: 
Pharmaceutical Technology, Pharmaceutical Technology-08-01-2001, Volume 2001 Supplement, Issue 2

The vulnerability of both the sponsors and the contractors has increased tremendously.

Related Content:

Bio/Pharma BusinessOutsourcingOutsourcing OutlookPharmaceutical Technology-08-01-2001
Charles River to Provide pDNA Manufacturing Services in Two Deals
Lonza Forms Agreement to Manufacture Acumen Pharmaceuticals’ AD mAb Therapy
Genmab Expands ADC Pipeline with $1.8 Billion Acquisition of ProfoundBio